Literature DB >> 22505973

The pattern of procalcitonin in primary total hip and knee arthroplasty and its implication in periprosthetic infection.

Syed Ali1, Andrew Christie, Andrew Chapel.   

Abstract

BACKGROUND: The serum marker Procalcitonin (PCT) has been shown to be a sensitive indicator of bacterial infection, but very little is known of its behavior in periprosthetic infection. In this study, PCT was compared with standard tests used to aid the diagnosis of infection. As a baseline, its pattern in uncomplicated hip and knee arthroplasty was investigated.
METHODS: A prospective study of fifty-nine patients had bloods taken preoperatively, and on days 1, 3, 5, for PCT, C- reactive protein, erythrocyte sedimentation rate and white cell count.
RESULTS: Fifty patients (85%) had normal PCT values (< 0.5 ng/ml) and only 5 recorded a value > 1.0ng/ml. On day 5 only 1 patient had a value > 0.5ng/ml. The standard tests all showed sporadic elevations over the 3 days. PCT levels are not significantly elevated by the trauma of this surgery, as they are in other surgical procedures.
CONCLUSIONS: PCT may be very useful in patients with suspected periprosthetic infection. KEYWORDS: Infection; Periprosthetic; Procalcitonin; C-reactive protein; Arthroplasty.

Entities:  

Year:  2009        PMID: 22505973      PMCID: PMC3318859          DOI: 10.4021/jocmr2009.04.1236

Source DB:  PubMed          Journal:  J Clin Med Res        ISSN: 1918-3003


Introduction

Two of the major complications of total knee and hip joint arthroplasty is peri-prosthetic infection and aseptic loosening. Many studies have investigated means of differentiating the two, mainly because the approach to revision arthroplasty and prognosis differs significantly between them. However, the diagnosis of peri-prosthetic infection still remains a difficult diagnosis [1]. Part of the explanation for this is the lack of reliability of the commonly used blood tests- C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and white cell count (WCC). A spectrum of inflammation naturally occurs in response to the tissue injury caused by surgery, commonly named the acute phase response. It has been shown that these blood parameters lack sensitivity and specificity in discriminating the inflammation of infection per se from that of the acute phase response [2-7]. Since the early 1990s there has been much interest addressing whether procalcitonin (PCT) is a more specific marker in detecting early bacterial infection in the perioperative period. Although they have often given conflicting results, it is largely believed that PCT is a more accurate indicator of infection [8-10]. PCT is a precursor of the hormone calcitonin, and is detectable in the serum of healthy individuals at a concentration of less than 0.5 ng/ml. Bacterial endotoxin has been shown to directly release PCT into the circulation [11, 12]. However, it is also elevated by the acute phase response [8], and this has resulted in much debate in the literature as to what cut-off value should represent infection [3, 13]. This has caused ambiguous conclusions in different studies regarding the superiority of PCT. This has been largely seen in abdominal and cardiothoracic surgery, as well as intensive care medicine. This is partly because these operations commonly cause a severe inflammatory response including the Systemic Inflammatory Response Syndrome-in non-infectious cases [8, 14-16]. Very few studies have looked at PCT in orthopaedics, and have only included small subgroups of patients in groups of patients undergoing different types of surgery [17]. Thus it appeared worthwhile to perform a study looking specifically at the characteristics of PCT in orthopaedic surgery. The aim of this study is therefore twofold: to illustrate the pattern of PCT in comparison to the routine inflammatory markers and, from this, to show if PCT could have a clinical role in periprosthetic infection.

Materials and Methods

A prospective study over 6 months of fifty-nine patients undergoing either primary total hip or knee arthroplasty was performed. The mean age was 70.5 years, involving 19 men and 40 women. There were no exclusion criteria, and the study was sponsored by NHS Argyll and Clyde. Written informed consent was obtained. Prophylactic cefuroxime was given at induction of anesthesia followed by 2 post-operative doses. Serum blood samples for PCT, CRP, ESR and WCC were taken pre-operatively and on days 1, 3 and 5 post-operatively. Blood pressure, pulse, respiratory rate and temperature were also recorded on these days. None of the patients showed any clinical sign of infection during their stay in hospital. Hospital records were reviewed after their routine 6 week follow-up appointments. All the patients had been subsequently referred to the nurse lead arthroplasty clinic, indicating no clinical suspicion of infection. The data was analysed by a statistician. PCT was measured using the Lumitest PCT-Q (Brahms Diagnostica, Germany).

Results

The descriptive statistics of the measured variables are shown in Tables 1 and 2.
Table 1

Descriptive statistics of the average values for the parameters over the 3 post-operative days

VariableMeanSt DevMinimumQ1MedianQ3Maximum
AVE PCT0.50961.1170.30.30.30.310
AVE CRP87.2861.02103983121292
AVE ESR51.3631.37425.54877125
AVE WCC9.6722.5794.67.759.511.118.3
Table 2

Descriptive statistics for each parameter on all days

VariableMeanSt DevMinimumQ1MedianQ3Maximum
Day 0 PCT0.37970.61190.30.30.30.35
Day 1 PCT0.40510.34960.30.30.30.32
Day 3 PCT0.7981.8770.30.30.30.310
Day 5 PCT0.32540.10270.30.30.30.31
Day 0 CRP11.789.64210101062
Day 1 CRP75.3247.2212386698189
Day 3 CRP129.0262.441091120162292
Day 5 CRP57.4948.4710204691280
Day 0 ESR20.7617.3347142677
Day 1 ESR31.4225.594132542121
Day 3 ESR62.5630.484415988125
Day 5 ESR60.128.164425282122
Day 0 WCC7.7312.3293.46.17.8917.5
Day 1 WCC10.2612.84258.31011.818.3
Day 3 WCC9.9222.2295.77.99.810.918.3
Day 5 WCC8.8342.4514.678.810.216.3

PCT

Fifty patients (85%) had concentrations of PCT within the normal range (< 0.5 ng/ml) on all four days. In the remaining nine patients there was no significant day of occurrence of the maximum PCT level, and only five patients (8%) recorded a value > 1.0 ng/ml. Two patients had a value > 5 ng/ml. This was measured at 10 ng/ml on day 3. These patients had values of < 0.5 ng/ml on the other 3 days. One patient had a preoperative value > 0.5 ng/ml. Only 1 patient had a value > 0.5 ng/ml on day 5. The data is shown on Figure 1.
Figure 1

Concentrations of PCT.

Concentrations of PCT.

CRP, ESR and WCC

Nine patients had a preoperative CRP value above the normal range (< 10 mg/l ). The day of occurrence of the maximum value was day 3 in 71% of patients, day 1 in 20% and day 5 in 9%. The maximum recorded value was 292 mg/l on day 3. This patient's CRP was < 10mg/l on day 5. Thirteen patients had an ESR above a reference range of 30 mm/hr preoperatively. Days 3 and 5 had an equal distribution of patient's maximum values, (46% on each day). Two patients had a preoperative WCC >12000/mm3, and five patients (8%) had there maximum value on this day. Twenty nine (49%) had there maximum value on day 1, 34% on day 3 and 9% on day 5. This data is illustrated on Figures 2-4.
Figure 2

Changes of C-reactive protein.

Changes of C-reactive protein. Changes of erythrocyte sedimentation rate (ESR). Changes of white cell count (WCC).

Discussion

Procalcitonin is a polypeptide prohormone of calcitonin, mainly produced by the c-cells of the thyroid (8). It was initially described as a possible marker of infection in 1993 [18]. Since then there has been growing interest in the question of whether is a more specific marker of bacterial infection. Although it gas been shown to respond directly to bacterial endotoxin [11, 12], it is also stimulated by non-infective inflammation [8-10, 14, 15, 19, 20]. This has caused conflicting opinion regarding its superiority in this matter. Unsurprisingly, many papers have drawn comparisons with CRP. A meta-analysis of such papers [9] concluded that PCT was a more accurate marker of bacterial infection. However, many well designed studies have shown that PCT is no better than CRP [21-23]. There is further dispute in surgery because the severity of the natural inflammatory response (acute phase response) depends upon the type of operation. There is much debate as to what cut-off value of PCT differentiates infection from the acute phase response [3, 13]. Most studies have been in cardio-thoracic and abdominal surgery where cut-off values vary from 1- 10 ng/ml during the perioperative period [5, 9, 13, 15-17]. This is largely because these procedures commonly cause the systemic inflammatory response syndrome [8, 16, 24]. None of the patients in this study developed systemic inflammatory response syndrome (SIRS). The results convincingly show that hip and knee arthroplasty don't cause a significant rise in PCT. Measurements for diagnostic purposes are more helpful when the surgical trauma itself does not trigger considerable PCT release. It is also proposed that PCT is better than CRP in the perioperative period because secretions begin within 4 hours and peak at 8 hours. CRP peaks only after 36 hours [9, 25]. The behavior of CRP in hip and knee arthroplasty is well documented- a pronounced rise at day 2 or 3, followed by a sharp decline [25, 26]. These results show this pattern, suggesting that this group is typical representation of other such studies. The results also indicate the limited use of ESR and WCC in this setting. Interestingly, nine patients (15%) had elevated CRP levels preoperatively. The only significance in their medical background was that three had previously undergone either hip or knee arthroplasty. The PCT was normal in these patients. Further studies have looked into other serum markers, one such paper analysing interleukin-6 in periprosthetic infection [2]. They had to exclude several patients because this test is elevated by chronic inflammatory diseases. It would appear from this study that PCT isn't affected in this way. In summary, PCT may be a more reliable indicator of periprosthetic infection given the substantial proportion of patients with unexplained high CRP levels preoperatively. Also, because the surgery doesn't cause PCT to rise indicates that it could be used to monitor high risk patients in the immediate post- operative period. This is further supported by its rapid elevation in infection, and the fact that the CRP, ESR and WCC are still elevated during this period. This would further imply that PCT would be useful in monitoring patients after their revision surgery for periprosthetic infection when it is often difficult to know if the infection has been eradicated [4, 7]. A large multicentre study involving patients undergoing revision surgery for infection needs to be performed to validate these findings and assumptions.
  26 in total

1.  Serological detection of Gram-positive bacterial infection around prostheses.

Authors:  M Rafiq; T Worthington; S E Tebbs; R B Treacy; R Dias; P A Lambert; T S Elliott
Journal:  J Bone Joint Surg Br       Date:  2000-11

2.  Diagnosis of infection after total hip arthroplasty.

Authors:  T Itasaka; A Kawai; T Sato; S Mitani; H Inoue
Journal:  J Orthop Sci       Date:  2001       Impact factor: 1.601

3.  Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation.

Authors:  Lothar Hambach; Matthias Eder; Elke Dammann; Andreas Schrauder; Karl-Walter Sykora; Christian Dieterich; Philip Kirschner; Jürgen Novotny; Arnold Ganser; Bernd Hertenstein
Journal:  Haematologica       Date:  2002-06       Impact factor: 9.941

Review 4.  The diagnosis of prosthetic joint infection: current techniques and emerging technologies.

Authors:  Robin Patel; Douglas R Osmon; Arlen D Hanssen
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

5.  Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.

Authors:  O Selberg; H Hecker; M Martin; A Klos; W Bautsch; J Köhl
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

6.  Procalcitonin: a valuable indicator of infection in a medical ICU?

Authors:  E Suprin; C Camus; A Gacouin; Y Le Tulzo; S Lavoue; A Feuillu; R Thomas
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 7.  Procalcitonin as an acute phase marker.

Authors:  J Whicher; J Bienvenu; G Monneret
Journal:  Ann Clin Biochem       Date:  2001-09       Impact factor: 2.057

8.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

9.  Procalcitonin and infection in elderly patients.

Authors:  Fabien Stucker; François Herrmann; Jean-Daniel Graf; Jean-Pierre Michel; Karl Heinz Krause; Gaëtan Gavazzi
Journal:  J Am Geriatr Soc       Date:  2005-08       Impact factor: 5.562

10.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  4 in total

Review 1.  Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Luca Maria Sconfienza; Alberto Signore; Victor Cassar-Pullicino; Maria Adriana Cataldo; Olivier Gheysens; Olivier Borens; Andrej Trampuz; Klaus Wörtler; Nicola Petrosillo; Heinz Winkler; Filip M H M Vanhoenacker; Paul C Jutte; Andor W J M Glaudemans
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

2.  Serum Procalcitonin Levels in Postoperative Monitoring of Diabetic Patients with Posterior Lumber Vertebral Stabilization Surgery: A Prospective Comparative Study.

Authors:  İbrahim Hakkı Tör; Sedef Gülçin Ural
Journal:  Turk J Anaesthesiol Reanim       Date:  2022-06

3.  Comparison of Synovial Fluid and Serum Procalcitonin for Diagnosis of Periprosthetic Joint Infection: A Pilot Study in 32 Patients.

Authors:  Paphon Sa-Ngasoongsong; Siwadol Wongsak; Chavarat Jarungvittayakon; Kawee Limsamutpetch; Thanaphot Channoom; Viroj Kawinwonggowit
Journal:  Biomed Res Int       Date:  2018-10-01       Impact factor: 3.411

4.  Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Alberto Signore; Luca Maria Sconfienza; Olivier Borens; Andor W J M Glaudemans; Victor Cassar-Pullicino; Andrej Trampuz; Heinz Winkler; Olivier Gheysens; Filip M H M Vanhoenacker; Nicola Petrosillo; Paul C Jutte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-26       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.